Information Journal Paper
APA:
Copy. (2017). MTBVAC: attenuating the human pathogen of tuberculosis (TB) toward a promising vaccine against the TB epidemic. FRONTIERS IN IMMUNOLOGY, 8(-), 0-0. SID. https://sid.ir/paper/756310/en
Vancouver:
Copy. MTBVAC: attenuating the human pathogen of tuberculosis (TB) toward a promising vaccine against the TB epidemic. FRONTIERS IN IMMUNOLOGY[Internet]. 2017;8(-):0-0. Available from: https://sid.ir/paper/756310/en
IEEE:
Copy, “MTBVAC: attenuating the human pathogen of tuberculosis (TB) toward a promising vaccine against the TB epidemic,” FRONTIERS IN IMMUNOLOGY, vol. 8, no. -, pp. 0–0, 2017, [Online]. Available: https://sid.ir/paper/756310/en